VAERS 1657783
JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge JNJ 78436735
- Staat
- -
- Alter
- -
- Geschlecht
- M
- Eingang
- 31.08.2021
- Impfdatum
- 01.01.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
He received both Moderna Covid-19 shots in January & February of 2021 and he got the Johnson & Johnson shot today; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (He received both Moderna Covid-19 shots in January & February of 2021 and he got the Johnson & Johnson shot today) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product JNJ 78436735 for COVID-19 vaccination. Concurrent medical conditions included Lung disease and Immunocompromised. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of JNJ 78436735 (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (He received both Moderna Covid-19 shots in January & February of 2021 and he got the Johnson & Johnson shot today). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (He received both Moderna Covid-19 shots in January & February of 2021 and he got the Johnson & Johnson shot today) had resolved. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Immunocompromised; Lung disease
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -